logo
In This Issue/Research Watch/News-in-Brief/News from the IASLC Tobacco Control Committee
Towards a Molecular Classification of Pulmonary Sarcomatoid Carcinomas
Immune Signatures of Non–Small Cell Lung Cancer
Challenging Situations for Lung SBRT
Pleural IMRT after Lung-Sparing Cytoreduction for Mesothelioma: Mature Enough to Randomize
Mutational Profile from Targeted NGS Predicts Survival in LDCT Screening–Detected Lung Cancers
Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling
Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape
Prognostic Impact of the Findings on Thin-Section Computed Tomography in Patients with Subcentimeter Non–Small Cell Lung Cancer
Characteristics and Outcomes of Patients with Lung Cancer Harboring Multiple Molecular Alterations: Results from the IFCT Study Biomarkers France
Use of Stereotactic Ablative Radiotherapy (SABR) in Non–Small Cell Lung Cancer Measuring More Than 5 cm
Long-Term Outcomes of Salvage Stereotactic Ablative Radiotherapy for Isolated Lung Recurrence of Non–Small Cell Lung Cancer: A Phase II Clinical Trial
Improved Outcomes with Modern Lung-Sparing Trimodality Therapy in Patients with Malignant Pleural Mesothelioma
A Prognostic Scoring Model for the Utility of Induction Chemotherapy Prior to Neoadjuvant Chemoradiotherapy in Esophageal Cancer
Rethinking Autoantibody Signature Panels for Cancer Diagnosis
Heterogeneity in Immune Marker Expression after Acquisition of Resistance to EGFR Kinase Inhibitors: Analysis of a Case with Small Cell Lung Cancer Transformation
Spondylodiskitis after Dilatation of Esophageal Radiation Stenosis: A Suspect for Metastasis
Novel Mutations on EGFR Leu792 Potentially Correlate to Acquired Resistance to Osimertinib in Advanced NSCLC
Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer; Statistical Issue on Reproducibility Analysis
Reply to Letter “The Use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An International Reproducibility Study in a Demanding Set of Cases.”
A Rare Case of ROS1 and ALK Double Rearranged Non–Small Cell Lung Cancer
Successful AZD9291 Therapy in Advanced Non–Small Cell Lung Cancer after Failure of HM61713
Histologic Transformation in a Patient with Lung Cancer Treated with Chemotherapy and Pembrolizumab
VATS Thymectomy with 3D Vision: A Chance to Further Improve the Outcomes of Thymus Minimally Invasive Surgery
Successful Treatment with Gefitinib in Advanced Non–Small Cell Lung Cancer after Acquired Resistance to Osimertinib